Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: Does a disparity persist by ethnicity-race?

Clinical Drug Investigation

Volumn 32, Issue 2, 2012, Pages 139-144

  Sclar, David A ^a,b   Robison, Linda M ^a   Schmidt, Jennifer M ^a   Bowen, Kurt A ^a   Castillo, Leigh V ^a   Oganov, Ambartsum M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Washington Institute for Mental Illness Research and Training   (United States)

Author keywords

antidepressants; depression; ethnicity race; NAMCS; national ambulatory medical care survey; trends

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGED; AMBULATORY CARE; ARTICLE; DEPRESSION; DRUG USE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HEALTH CARE DISPARITY; HEALTH SURVEY; HISPANIC; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; PSYCHOPHARMACOTHERAPY; RACE DIFFERENCE; TREND STUDY; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; ANTIDEPRESSIVE AGENTS; CONTINENTAL POPULATION GROUPS; DEPRESSION; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES; YOUNG ADULT;

EID: 84855425157     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11598950-000000000-00000     Document Type: Article

References (31)

1. Franco K, Tamburino M, Campbell N, et al. The added costs of depression to medical care. Pharmacoeconomics 1995; 7: 284-91
2. Hall RC, Wise MG. The clinical and financial burden of mood disorders: cost and outcome. Psychosomatics 1995; 36 Suppl. 2: S11-8
3. Johnson J, Weissman M, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992; 267: 1478-83
4. Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289 (23): 3095-105 (Pubitemid 37432885)
5. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003; 64 (12): 1465-75 (Pubitemid 41270106)
6. Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 2003; 12 (1): 3-21 (Pubitemid 36675444)
7. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002; 287: 203-9 (Pubitemid 34251945)
8. Skaer TL, Sclar DA, Robison LM, et al. Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US: an assessment of office-based visits 1990 to 1998. CNS Drugs 2000; 14: 473-81 (Pubitemid 32042677)
9. Simpson SM, Krishnan LL, Kunik ME, et al. Racial disparities in diagnosis and treatment of depression: a literature review. Psychiatr Q 2007; 78: 3-14 (Pubitemid 46155634)
10. Sclar DA, Robison LM, Skaer TL. Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States. Int Clin Psychopharmacol 2008; 23: 106-9 (Pubitemid 351317283)
11. Melfi CA, Croghan TW, Hanna MP, et al. Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry 2000; 61: 16-21 (Pubitemid 30104378)
12. Sclar DA, Robison LM, Skaer TL, et al. Antidepressant prescribing patterns: a comparison of blacks and whites in a Medicaid population. Clin Drug Investig 1998; 16: 135-40 (Pubitemid 28430057)
13. Sclar DA, Robison LM, Skaer TL, et al. Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995. Harv Rev Psychiatry 1999; 7: 29-36 (Pubitemid 29426050)
14. Skaer TL, Sclar DA, Robison LM, et al. Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992-1997. Clin Ther 2000; 22: 1575-89 (Pubitemid 32056095)
15. National Center for Health Statistics. Centers for Disease Control and Prevention. U.S. NAMCS: National Ambulatory Medical Care Survey, 1992-1997, 2003-2008 [online]. Available from URL: http://www.cdc.gov/nchs/ahcd.htm [Accessed 2011 Oct 10]
16. Bryant E, Shimizu I. Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. National Center for Health Statistics. Vital Health Stat 1988; 2: 1-39
17. U.S. Public Health Service and Health Care Financing Administration. International classification of diseases, 9th revision, clinical modification, volume 1. DHHS publication no. (PHS) 89-1260. Washington, DC: Public Health Service, 1989
18. Food and Drug Administration. National Drug Code Directory 1995 edition. Washington, DC: Public Health Service, 1995
19. Koch H, Campbell W. The collection and processing of drug information. National Ambulatory Medical Care Survey, 1980. National Center for Health Statistics, Vital Health Stat 1982; 2: 1-90
20. Cerner Multum, Inc. [online]. Available from URL: http://www.multum.com/ Lexicon.htm, [Accessed 2011 Feb 23]
21. U.S. Census Bureau. National population estimates for the 1990's: monthly postcensal resident population, by single year of age, sex, race, and Hispanic origin. Washington, DC: Population Estimates Program Population Division [online]. Available from URL: http://www.census.gov/pop ulation/www/estimates/ nat-90s-1.html [Accessed 2007 Jun 6]
22. U.S. Census Bureau. National population estimates-characteristics. National sex, age, race and Hispanic origin: April 1, 2000 to July 1, 2008. Washington, DC: Population Estimates Program Population Division [online]. Available from URL: http://www.census.gov/popest/national/asrh/NC-EST2008-asrh. html [Accessed 2010 Oct 22]
23. Sclar DA, Skaer TL, Robison LM, et al. Economic appraisal of citalopram in the management of single-episode depression. J Clin Psychopharmacol 1999; 19 Suppl. 1: 47S-54S (Pubitemid 29451501)
24. Strothers 3rd HS, Rust G, Minor P, et al. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression. J Am Geriatr Soc 2005; 53 (3): 456-61 (Pubitemid 41623525)
25. Stockdale SE, Lagomasino IT, Siddique J, et al. Racial and ethnic disparities in detection and treatment of depression and anxiety among psychiatric and primary health care visits, 1995-2005. Medical Care 2008; 46 (7): 668-77
26. Sclar DA, Skaer TL, Robison LM, et al. Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis. J Clin Psychiatry 1998; 59 Suppl. 2: 13-7 (Pubitemid 28155484)
27. Skaer TL, Sclar DA, Robison LM, et al. The need for an iterative process for assessing economic outcomes associated with selective serotonin reuptake inhibitors. Phar-macoeconomics 2000; 18: 205-14
28. Sclar DA, Robison LM, Skaer TL, et al. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. Int J Psychiatry Med 1998; 28: 447-59
29. Robison LM, Skaer TL, Sclar DA, et al. Is attentiondeficit/hyperactivity disorder increasing among girls in the U.S.? Trends indiagnosis and the prescribing of stimulants. CNS Drugs 2002; 16: 129-37 (Pubitemid 34155209)
30. Gonzalez HM, Vega WA, Williams DR, et al. Depression care in the United States: too little for too few. Arch Gen Psychiatry 2010; 67: 37-46
31. Alegria M, Chatterji P, Wells K, et al. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psych Services 2008; 59: 1264-72